Page 19 - Acb News Today

Australia's competition regulator said on Friday it has declined to reauthorise an agreement between Virgin Australia and Alliance Aviation Services to jointly provide fly-in and fly-out (FIFO) services to their corporate clients.

Brazil's government and judiciary objected on Tuesday to big tech firms campaigning against an internet regulation bill aimed at cracking down on fake news, alleging undue interference in the debate in Congress.

A case is registered against Gowtham, Srinivas and Prasad. All the three persons are arrested and produced before the court.

A Connecticut federal judge on Friday acquitted six aerospace engineering managers charged with conspiring to restrict employee hiring and recruitment, in a ruling that marked another loss for the U.S. Justice Department in its series of labor-related antitrust prosecutions.

Mastercard Inc on Thursday said the U.S. Justice Department was conducting an antitrust investigation of its U.S. debit program and competition with other payment networks.

A trap was laid by the ACB team and the accused persons were caught accepting Rs 80,000 bribe amount from the complainant.

Italy's antitrust authority said on Friday it had taken measures against Meta Platform over an alleged abuse of its position in the country, in a probe involving the rights to music posted on the group's platforms.

Aurora Cannabis (NYSE:ACB – Get Rating) and Mind Medicine (MindMed) (NASDAQ:MNMD – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, profitability, valuation, analyst recommendations, risk and earnings. Earnings and Valuation This table compares Aurora Cannabis […]

European Union antitrust regulators have started inspecting a facility of luxury goods company Gucci as part of an EU investigation spanning several countries, Gucci's French owner Kering said on Wednesday confirming a Reuters report.

Aurora Cannabis Inc. (NYSE:ACB – Get Rating) has been given a consensus rating of “Hold” by the seven brokerages that are presently covering the company, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average twelve-month target price […]